- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aryx Therapeutics, I (ARYX)
Aryx Therapeutics, I stock price live, this page displays OTC ARYX stock exchange data. View the ARYX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aryx Therapeutics, I real time stock price chart below.
What Is the Aryx Therapeutics, I Stock Price Today?
The Aryx Therapeutics, I stock price today is 0.0000.
What Is the Stock Symbol for Aryx Therapeutics, I?
The stock symbol for Aryx Therapeutics, I is "ARYX."
What Stock Exchange Does Aryx Therapeutics, I Trade On?
Aryx Therapeutics, I is listed and trades on the OTC Markets stock exchange.
Is Aryx Therapeutics, I a Good Stock to Buy?
Determining whether Aryx Therapeutics, I—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARYX quote. (ISIN: US0433871094)
What Is the Aryx Therapeutics, I Stock Price Today?
The Aryx Therapeutics, I stock price today is 0.0000.
What Is the Stock Symbol for Aryx Therapeutics, I?
The stock symbol for Aryx Therapeutics, I is "ARYX."
What Stock Exchange Does Aryx Therapeutics, I Trade On?
Aryx Therapeutics, I is listed and trades on the OTC Markets stock exchange.
Is Aryx Therapeutics, I a Good Stock to Buy?
Determining whether Aryx Therapeutics, I—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARYX quote. (ISIN: US0433871094)
OTC Markets
Currency in USD
0.0000
0.0000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0000
0.0000
52 wk Range
0.0000
0.0012
ARYX Scorecard
Full Analysis
Stock generally trades with low price volatility
ARYX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00000.0000
52 wk Range
0.00000.0012
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ARYX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Aryx Therapeutics, I Company Profile
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; and Budiodarone (ATI-2042), an oral antiarrhythmic agent that is in Phase IIb clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat. The company’s other clinical development products comprise ATI-7505, an oral prokinetic agent, which is in Phase IIb clinical development for the treatment of chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease; and ATI-9242, an antipsychotic agent in Phase I clinical development for the treatment of schizophrenia and other psychiatric disorders. It also focuses on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal disorders that are in discovery stage. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California.
Compare ARYX to Peers and Sector
Metrics to compare | ARYX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARYXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.5x | −0.5x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 0.0x | 0.6x | 2.6x | |
Price / LTM Sales | 0.0x | 1.6x | 3.1x | |
Upside (Analyst Target) | 0.0% | 122.2% | 45.7% | |
Fair Value Upside | Unlock | 10.4% | 5.7% | Unlock |
Earnings
Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the Aryx Therapeutics, I (ARYX) Stock Price Today?
The Aryx Therapeutics, I stock price today is 0.00
What Stock Exchange Does Aryx Therapeutics, I Trade On?
Aryx Therapeutics, I is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Aryx Therapeutics, I?
The stock symbol for Aryx Therapeutics, I is "ARYX."
What Is the Aryx Therapeutics, I Market Cap?
As of today, Aryx Therapeutics, I market cap is 33.00.
What Is Aryx Therapeutics, I's Earnings Per Share (TTM)?
The Aryx Therapeutics, I EPS (TTM) is -0.59.
From a Technical Analysis Perspective, Is ARYX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aryx Therapeutics, I Stock Split?
Aryx Therapeutics, I has split 0 times.
How Many Employees Does Aryx Therapeutics, I Have?
Aryx Therapeutics, I has 56 employees.
What is the current trading status of Aryx Therapeutics, I (ARYX)?
As of Jul 12, 2025, Aryx Therapeutics, I (ARYX) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.